Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by PoorOpinionon Jan 15, 2018 1:14pm

105 Views

Post# 27360254

RE:RE:RE:RE:RE:RE:RE:RE:Taimed Stock hopping tonight

Where's spinky? Every little market move he see's leaked news, shouldnt Taimed's move be telling you approval is near? And everybody else if you dont like when spinky calls the negative moves signs of rejection maybe you shouldnt be calling a positive move as signs of approval, just sayin'.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?